<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="92d5708d-4f74-47b5-82d5-1d35b1fe98a4"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Ella Fitzgerald</title>
  <effectiveTime value="20260810120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="a45c29be-63f1-45e1-abb4-78a21b9b5cda"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="a87d5a88-726b-4149-b058-8a69daa31b19" extension="HR-ML029-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-29-3640"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Ella</given><family>Fitzgerald</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19560425"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260810120000-0500"/>
    <assignedAuthor><id root="6f56361b-b1bd-4963-b231-dc204bfd3300"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Odessa</given><family>Whitlow</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260810120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="6f56361b-b1bd-4963-b231-dc204bfd3300"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Odessa</given><family>Whitlow</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="6f56361b-b1bd-4963-b231-dc204bfd3300"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Odessa</given><family>Whitlow</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="44170762-824d-46ec-8f99-91c2a5a684ce"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>Three-month review: A1c, lipids, walking program, eye treatment, and foot care</originalText></code>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="6f56361b-b1bd-4963-b231-dc204bfd3300"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Odessa</given><family>Whitlow</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>Three-month review: A1c, lipids, walking program, eye treatment, and foot care. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Fitzgerald returns three months after her first visit, after a two-week run of concerts. She completed ten weeks of the supervised exercise program and walked to the home plan on tour; she can now walk about three blocks before calf pain, and the pain eases faster. She has had three right-eye injections, and her right eye is clearer. The podiatrist pared her calluses and she now performs in low-heeled custom stage shoes. Her glucose monitor shows time in range 66% and time below 70 mg/dL 0.8%, with no reading below 54 mg/dL; she ate before every late show. She has had no bleeding on rivaroxaban and aspirin. Her hepatitis C screening test was negative. She would like to know whether anything else can help her legs and her glucose. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>Glucose</td><td>Time in range 66%; time below 70 mg/dL 0.8%; none below 54</td></tr><tr><td>Walking</td><td>About three blocks, from one and a half</td></tr><tr><td>Eye treatment</td><td>Three right-eye injections; vision clearer</td></tr><tr><td>Feet</td><td>Calluses pared; low-heeled stage shoes</td></tr><tr><td>Bleeding</td><td>None</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Cardiovascular</td><td>Positive</td><td>Calf pain after about three blocks; no chest pain or rest pain</td></tr><tr><td>Eyes</td><td>Positive</td><td>Right-eye blur better</td></tr><tr><td>Hematologic</td><td>Negative</td><td>No bruising, nosebleeds, or blood in the urine or stool</td></tr><tr><td>Integumentary</td><td>Negative</td><td>No foot sores</td></tr></tbody></table><paragraph>4 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals</td><td>One tablet by mouth twice daily with breakfast and the evening meal</td><td>Oral route</td><td>2016-03-01</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Glipizide 10 mg oral tablet, one tablet by mouth twice daily before meals</td><td>One tablet by mouth twice daily before breakfast and the evening meal</td><td>Oral route</td><td>2021-09-01 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-3"><td>Insulin glargine 100 units/mL pen, 30 units under the skin at bedtime</td><td>30 units at bedtime</td><td>Subcutaneous route</td><td>2023-04-01 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-4"><td>Insulin glargine 100 units/mL pen, 24 units under the skin each morning</td><td>24 units each morning, at the same clock time on tour, with written time-zone adjustments</td><td>Subcutaneous route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-5"><td>Atorvastatin 40 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02 to 2026-05-11</td><td>completed</td><td>S</td></tr><tr ID="medication-6"><td>Atorvastatin 80 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-7"><td>Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-8"><td>Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2025-06-02</td><td>active</td><td>S</td></tr><tr ID="medication-9"><td>Empagliflozin 10 mg oral tablet, one tablet by mouth each morning</td><td>One tablet by mouth each morning; hold on days she cannot eat or drink normally and before surgery</td><td>Oral route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-10"><td>Glucagon 3 mg nasal powder, one spray into one nostril for a severe low glucose</td><td>One spray into one nostril if she cannot safely swallow during a low glucose; may repeat once after 15 minutes with a new device; call 911</td><td>Nasal route</td><td>2026-05-11</td><td>active</td><td>S</td></tr><tr ID="medication-11"><td>Rivaroxaban 2.5 mg oral tablet, one tablet by mouth twice daily with aspirin 81 mg</td><td>One tablet by mouth twice daily, with aspirin 81 mg once daily</td><td>Oral route</td><td>2026-05-26</td><td>active</td><td>S</td></tr><tr ID="medication-12"><td>Semaglutide 0.25 mg under the skin once weekly for four weeks</td><td>0.25 mg once weekly on the same day each week for four weeks</td><td>Subcutaneous route</td><td>2026-08-10 to 2026-09-07</td><td>completed</td><td>S</td></tr><tr ID="medication-14"><td>Ezetimibe 10 mg oral tablet, one tablet by mouth daily</td><td>One tablet by mouth daily</td><td>Oral route</td><td>2026-08-10</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="4b26143e-288f-42fe-a35b-291515342369"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20160301"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="861004" codeSystem="2.16.840.1.113883.6.88" displayName="metformin hydrochloride 1000 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="eb38b151-2d87-4cf1-9bfd-da3a5ebda59a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="0aad3558-f4d0-4e3c-851d-73cc3eac3ed7"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20210901"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="310488" codeSystem="2.16.840.1.113883.6.88" displayName="glipizide 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="8d0c37d3-4add-4506-a0bd-972b7cc1ea79"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="26a6b04d-8c1b-4483-82c4-6530ab1c2f61"/>
      <text><reference value="#medication-3"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20230401"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Subcutaneous route"/>
      <doseQuantity value="30" unit="[IU]"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="847230" codeSystem="2.16.840.1.113883.6.88" displayName="3 ML insulin glargine 100 UNT/ML Pen Injector"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e01e8d4f-f96b-4250-bec0-8bcde89bb958"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="075ddc8a-51f8-4221-a2a5-b26403af1fe7"/>
      <text><reference value="#medication-4"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Subcutaneous route"/>
      <doseQuantity value="24" unit="[IU]"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="847230" codeSystem="2.16.840.1.113883.6.88" displayName="3 ML insulin glargine 100 UNT/ML Pen Injector"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="fbdd7a61-39a8-4fae-87ad-8515cc958b49"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="e25dc7fd-067a-484d-b726-5e1c7f797b2e"/>
      <text><reference value="#medication-5"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/><high value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="617311" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 40 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="9b9ba92a-f027-44e0-9be1-282fde3c62a2"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="ca957e1f-e199-4cb4-849b-9fa7481bc9fc"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b29d2b2c-85b2-45fb-96e3-2e1f7b663001"/>
      <text><reference value="#medication-6"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="259255" codeSystem="2.16.840.1.113883.6.88" displayName="atorvastatin 80 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="a909b55d-7422-42c4-8e05-27c3415230ec"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="f80bfa8a-19fd-4fa1-94cd-88c3fdcd83d5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c95dda93-64f9-4682-8322-0c5f4eb1ac9b"/>
      <text><reference value="#medication-7"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="308416" codeSystem="2.16.840.1.113883.6.88" displayName="aspirin 81 MG Delayed Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="e4214ffc-a800-41e3-966d-ffe59cea5e1f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="962a3085-cddc-4260-bfac-35cbc3cf70d5"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="58d6b2af-99f9-4a98-92ed-2b40b79e194c"/>
      <text><reference value="#medication-8"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20250602"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="866427" codeSystem="2.16.840.1.113883.6.88" displayName="metoprolol succinate 25 MG 24HR Extended Release Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="d7e15ee8-be43-401a-b14b-3aa371c7759d"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="378fde12-bae9-4c70-b9d8-023bb770f500"/>
      <text><reference value="#medication-9"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="1545658" codeSystem="2.16.840.1.113883.6.88" displayName="empagliflozin 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="7b44054e-9d15-4950-8cdc-e33e0e775e6a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="699c3ba4-d726-420a-af1e-b089eac9025c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c6dfdba1-f74c-4cd2-bda0-323471b63c1f"/>
      <text><reference value="#medication-10"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260511"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="15" unit="min"/></effectiveTime>
      <routeCode code="C38284" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Nasal route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2180666" codeSystem="2.16.840.1.113883.6.88" displayName="glucagon 3 MG Nasal Powder"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="06202602-4da2-47b3-85c0-851f69f902af"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="b1db6fdb-4009-4cc3-814e-efdc64550f20"/>
      <text><reference value="#medication-11"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260526"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2059015" codeSystem="2.16.840.1.113883.6.88" displayName="rivaroxaban 2.5 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="505e9d46-79b6-466b-9dd4-f6bdd1afaeea"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5aeb8d53-4dc1-471b-998a-8ed637a42e7f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c9c546d2-81b5-49da-bafb-1bf484a2213c"/>
      <text><reference value="#medication-12"/></text>
      <statusCode code="completed"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260810"/><high value="20260907"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="wk"/></effectiveTime>
      <routeCode code="C38299" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Subcutaneous route"/>
      <doseQuantity value="0.25" unit="mg"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="2619152" codeSystem="2.16.840.1.113883.6.88" displayName="0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="5075d543-bfab-44cf-b22f-456c7c47481f"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="29090091-44ab-4a93-86f2-272c0614f2fc"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="c642788c-953d-4dc6-90fe-94f17c4f702a"/>
      <text><reference value="#medication-14"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260810"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="349556" codeSystem="2.16.840.1.113883.6.88" displayName="ezetimibe 10 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="864d73cc-27de-4263-956a-92246dd3986e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="6f440ca3-89df-44dc-a9cf-47214ef15b33"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="090bf46c-bcfd-4d57-87db-d967d5a84ba3"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="5ec2e7c2-ee03-4ab4-8f05-122f556ce9db"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-3-1"><td>2026-08-10</td><td>Body height</td><td>165</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-3-2"><td>2026-08-10</td><td>Body weight</td><td>82.1</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-3-3"><td>2026-08-10</td><td>Body mass index (BMI) [Ratio]</td><td>30.2</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-3-4"><td>2026-08-10</td><td>Systolic blood pressure</td><td>122</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-5"><td>2026-08-10</td><td>Diastolic blood pressure</td><td>68</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-3-6"><td>2026-08-10</td><td>Heart rate</td><td>62</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-7"><td>2026-08-10</td><td>Respiratory rate</td><td>16</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-3-8"><td>2026-08-10</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-3-9"><td>2026-08-10</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>97</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="7a10f44c-b06e-47ec-bf9d-a0a4ecd53174"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260810"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="bcb64f43-0671-4254-8308-9db4494ce9a7"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-3-1"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="165" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b64dc4ac-4f20-4de4-ac7b-151f25e32218"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-3-2"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="82.1" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="cd7aa12c-02c8-4df7-baf0-96fca17948ad"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-3-3"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="30.2" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="6b1e3acf-8458-499e-827f-7e4a870daed8"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-3-4"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="122" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="233ebea6-cae3-4f15-b1df-ae12a272fcd8"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-3-5"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="68" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="b336c8ca-8205-4c3e-a5bd-73415ac03818"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-3-6"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="62" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="27a3c865-8fae-4fb6-a9b4-4ebb4730253a"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-3-7"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="16" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="5a46aa4b-bea9-4944-85c8-b882d13a8576"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-3-8"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3c42c9fa-c081-46a8-8dbe-e866ceb31c2a"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-3-9"/></text><statusCode code="completed"/><effectiveTime value="20260810"/><value xsi:type="PQ" value="97" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-25"><td>2026-08-10</td><td>Hemoglobin A1c/Hemoglobin.total in Blood</td><td>7.6</td><td>%</td><td>Below 5.7% is normal; her individualized goal is below 7.5%</td><td>High</td><td>S</td></tr>
  <tr ID="result-26"><td>2026-08-10</td><td>Sodium [Moles/volume] in Serum or Plasma</td><td>140</td><td>mmol/L</td><td>135-145 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-27"><td>2026-08-10</td><td>Potassium [Moles/volume] in Serum or Plasma</td><td>4.6</td><td>mmol/L</td><td>3.5-5.1 mmol/L</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-28"><td>2026-08-10</td><td>Creatinine [Mass/volume] in Serum or Plasma</td><td>0.96</td><td>mg/dL</td><td>0.59-1.04 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-29"><td>2026-08-10</td><td>Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M</td><td>64</td><td>mL/min/{1.73_m2}</td><td>&gt;=60 mL/min/1.73 m²</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-30"><td>2026-08-10</td><td>Cholesterol [Mass/volume] in Serum or Plasma</td><td>128</td><td>mg/dL</td><td>&lt;=199 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-31"><td>2026-08-10</td><td>Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation</td><td>64</td><td>mg/dL</td><td>Her goal with coronary and peripheral artery disease is below 55 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-32"><td>2026-08-10</td><td>Cholesterol in HDL [Mass/volume] in Serum or Plasma</td><td>46</td><td>mg/dL</td><td>&gt;=50 mg/dL</td><td>Low</td><td>S</td></tr>
  <tr ID="result-33"><td>2026-08-10</td><td>Triglyceride [Mass/volume] in Serum or Plasma</td><td>112</td><td>mg/dL</td><td>&lt;=149 mg/dL</td><td>Normal</td><td>S</td></tr>
  <tr ID="result-34"><td>2026-08-10</td><td>Visual acuity best corrected Right eye by ETDRS eye chart</td><td>71</td><td>{letters}</td><td>85 letters is about 20/20; 80 about 20/25; 65 about 20/50</td><td>Low</td><td>S</td></tr>
  <tr ID="result-35"><td>2026-08-10</td><td>Visual acuity best corrected Left eye by ETDRS eye chart</td><td>81</td><td>{letters}</td><td>85 letters is about 20/20; 80 about 20/25; 65 about 20/50</td><td>Normal</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="c0900857-cc1a-45be-9123-072ccd1939f1"/>
      <code code="4548-4" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin A1c/Hemoglobin.total in Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="8c167f11-48d6-44ad-9561-2351a08b11d8"/>
          <code code="4548-4" codeSystem="2.16.840.1.113883.6.1" displayName="Hemoglobin A1c/Hemoglobin.total in Blood"/>
          <text><reference value="#result-25"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="7.6" unit="%"/>
          <interpretationCode code="H" codeSystem="2.16.840.1.113883.5.83" displayName="High"/>
          <referenceRange>
            <observationRange>
              <text>Below 5.7% is normal; her individualized goal is below 7.5%</text>
              <value xsi:type="IVL_PQ"><high value="5.6" unit="%"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5617ec5a-9117-4d45-8be1-0f5bf9bc46b8"/>
      <code code="51990-0" codeSystem="2.16.840.1.113883.6.1" displayName="Basic metabolic panel - Blood"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="d15e41e1-7e02-4326-bb1c-093dda6753ca"/>
          <code code="2951-2" codeSystem="2.16.840.1.113883.6.1" displayName="Sodium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-26"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="140" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>135-145 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="135" unit="mmol/L"/><high value="145" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0f1d7e15-e556-4171-a6e0-634353831d12"/>
          <code code="2823-3" codeSystem="2.16.840.1.113883.6.1" displayName="Potassium [Moles/volume] in Serum or Plasma"/>
          <text><reference value="#result-27"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="4.6" unit="mmol/L"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>3.5-5.1 mmol/L</text>
              <value xsi:type="IVL_PQ"><low value="3.5" unit="mmol/L"/><high value="5.1" unit="mmol/L"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="1a914197-9eac-42b2-b221-027cf500c1dc"/>
          <code code="2160-0" codeSystem="2.16.840.1.113883.6.1" displayName="Creatinine [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-28"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="0.96" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>0.59-1.04 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="0.59" unit="mg/dL"/><high value="1.04" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="e1e43d79-eae1-4d62-af58-f4ef00059d14"/>
          <code code="98979-8" codeSystem="2.16.840.1.113883.6.1" displayName="Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M"/>
          <text><reference value="#result-29"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="64" unit="mL/min/{1.73_m2}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=60 mL/min/1.73 m²</text>
              <value xsi:type="IVL_PQ"><low value="60" unit="mL/min/{1.73_m2}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="dfdafecb-59f4-478e-a92c-998cc2d8bd26"/>
      <code code="2093-3" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="8d4a990b-b9d2-47ce-afdb-46460d8d6223"/>
          <code code="2093-3" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-30"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="128" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&lt;=199 mg/dL</text>
              <value xsi:type="IVL_PQ"><high value="199" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5e25a996-0782-4148-b9c0-b960860dc382"/>
      <code code="13457-7" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="d52eec4d-6db8-493e-ac81-4111bbb4e358"/>
          <code code="13457-7" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/>
          <text><reference value="#result-31"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="64" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>Her goal with coronary and peripheral artery disease is below 55 mg/dL</text>
              <value xsi:type="IVL_PQ"><high value="99" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5d51912c-6c9e-4f81-b2a3-f34bfbc1fb30"/>
      <code code="2085-9" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol in HDL [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="a5c3d9b9-7b7b-4e24-8e96-fcec63ab33bc"/>
          <code code="2085-9" codeSystem="2.16.840.1.113883.6.1" displayName="Cholesterol in HDL [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-32"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="46" unit="mg/dL"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>&gt;=50 mg/dL</text>
              <value xsi:type="IVL_PQ"><low value="50" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="5f196bb6-71e0-4e3d-bcee-d4fd26605534"/>
      <code code="2571-8" codeSystem="2.16.840.1.113883.6.1" displayName="Triglyceride [Mass/volume] in Serum or Plasma"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="55637e45-2139-4778-a228-3cb3b163b4e2"/>
          <code code="2571-8" codeSystem="2.16.840.1.113883.6.1" displayName="Triglyceride [Mass/volume] in Serum or Plasma"/>
          <text><reference value="#result-33"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="112" unit="mg/dL"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>&lt;=149 mg/dL</text>
              <value xsi:type="IVL_PQ"><high value="149" unit="mg/dL"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="bef682b9-5725-4a9e-a715-c8b2a05e4e36"/>
      <code code="79876-9" codeSystem="2.16.840.1.113883.6.1" displayName="Visual acuity best corrected Right eye by ETDRS eye chart"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="64eb985d-5d99-42d1-aa1e-25cd8f76ac4d"/>
          <code code="79876-9" codeSystem="2.16.840.1.113883.6.1" displayName="Visual acuity best corrected Right eye by ETDRS eye chart"/>
          <text><reference value="#result-34"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="71" unit="{letters}"/>
          <interpretationCode code="L" codeSystem="2.16.840.1.113883.5.83" displayName="Low"/>
          <referenceRange>
            <observationRange>
              <text>85 letters is about 20/20; 80 about 20/25; 65 about 20/50</text>
              <value xsi:type="IVL_PQ"><low value="80" unit="{letters}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="4e61bee3-0837-4701-9cfc-a15ffc9db2f5"/>
      <code code="79877-7" codeSystem="2.16.840.1.113883.6.1" displayName="Visual acuity best corrected Left eye by ETDRS eye chart"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260810"/><high value="20260810"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="612c9ce1-1a9f-4ab0-bdd6-57be33125557"/>
          <code code="79877-7" codeSystem="2.16.840.1.113883.6.1" displayName="Visual acuity best corrected Left eye by ETDRS eye chart"/>
          <text><reference value="#result-35"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260810"/>
          <value xsi:type="PQ" value="81" unit="{letters}"/>
          <interpretationCode code="N" codeSystem="2.16.840.1.113883.5.83" displayName="Normal"/>
          <referenceRange>
            <observationRange>
              <text>85 letters is about 20/20; 80 about 20/25; 65 about 20/50</text>
              <value xsi:type="IVL_PQ"><low value="80" unit="{letters}"/></value>
            </observationRange>
          </referenceRange>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-08-10; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Well; weight 82.1 kg, BMI 30.2; blood pressure 122/68, pulse 62</td></tr><tr><td>Feet</td><td>Skin intact; small calluses; hammer toes; no ulcer; monofilament felt at all sites; right foot pulses absent, left faint; shoes fit well</td></tr><tr><td>Eyes</td><td>Best-corrected acuity 71 letters right and 81 letters left</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Type 2 diabetes mellitus with peripheral artery disease: cramping in both calves after about one and a half blocks of walking, worse on the right, easing within minutes of rest; no rest pain, wounds, or color change. Resting ankle-brachial index 0.62 right and 0.74 left, toe-brachial index 0.46 and 0.55; dorsalis pedis and posterior tibial pulses absent on the right and faint on the left. A1c 8.6% on metformin, glipizide and glargine, with low glucose readings (to 52 mg/dL) after late performances. Foot: protective sensation intact to the 10-g monofilament at all sites and to vibration; callus under the second metatarsal heads; hammer toes of the second and third toes; no ulcer (IWGDF risk category 2). Synthetic modern episode linked to her documented diabetes and its circulatory complications</td><td>active</td><td>confirmed</td>
    <td>E11.51</td><td>S — Synthetic modern diagnosis; the type of diabetes was not made public and is synthetic.</td>
  </tr>
  <tr ID="problem-2">
    <td>Moderate nonproliferative diabetic retinopathy with center-involving diabetic macular edema in the right eye (best-corrected acuity 64 letters, about 20/50) and moderate nonproliferative retinopathy without macular edema in the left eye (81 letters); lens implants in both eyes from earlier cataract surgery. Synthetic modern episode linked to her documented diabetic eye problems</td><td>active</td><td>confirmed</td>
    <td>E11.3311</td><td>S — Synthetic modern eye diagnosis on retinal imaging and optical coherence tomography in the clinic; the left eye is described in the display.</td>
  </tr>
  <tr ID="problem-3">
    <td>Coronary artery disease after five-vessel coronary bypass surgery last year, with an intensive care stay; no angina now; on aspirin, a statin, and metoprolol. Synthetic modern episode linked to her documented heart surgery</td><td>active</td><td>confirmed</td>
    <td>I25.10</td><td>S — Synthetic modern coding of her documented heart surgery; bypass grafts are described in the display.</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="5b0461d3-b82c-4fff-b2aa-ff31d4cea825"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="e0d8b117-7cdf-4010-a5bf-8e651e560d13"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="E11.51" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="4cce2fc3-9404-4542-98db-1ad48a7b27ba"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="dc85bf27-121a-4eb1-9a13-97c6495eb11c"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="E11.3311" codeSystem="2.16.840.1.113883.6.90" displayName="Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="1a7b2058-87aa-4d77-af33-b962bf5717b3"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260511"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="cfdb83a3-730d-43f4-8156-fc9e5585167a"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260511"/></effectiveTime>
          <value xsi:type="CD" code="I25.10" codeSystem="2.16.840.1.113883.6.90" displayName="Atherosclerotic heart disease of native coronary artery without angina pectoris"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Type 2 diabetes with peripheral artery disease (E11.51)</content>. A1c 7.6%, from 8.6%, without level 2 lows; still just above her goal below 7.5%. Walking distance has doubled with supervised exercise. With coronary and peripheral artery disease, a GLP-1 receptor agonist adds cardiovascular protection, and in people with peripheral artery disease and type 2 diabetes semaglutide has increased walking distance. Because a fast fall in glucose can briefly worsen retinopathy, the retina clinic was told before the start and the dose will rise slowly. Creatinine 0.96 mg/dL and eGFR 64, a small expected change on empagliflozin; potassium 4.6 mmol/L. [S]<list><item>Start semaglutide 0.25 mg weekly for four weeks, then 0.5 mg weekly.</item><item>Eat smaller meals and stop eating when full; call for persistent vomiting or abdominal pain.</item><item>Continue glargine 24 units; lower it if fasting readings fall below 90 mg/dL.</item><item>Finish the twelve weeks of supervised exercise, then walk at least three times a week.</item></list></item><item><content styleCode="Bold">Coronary artery disease after bypass surgery (I25.10)</content>. LDL 64 mg/dL on atorvastatin 80 mg, above the goal below 55 mg/dL; HDL 46 and triglycerides 112 mg/dL. No angina. [S]<list><item>Add ezetimibe 10 mg daily.</item><item>Lipid panel in 4 to 12 weeks.</item></list></item><item><content styleCode="Bold">Diabetic macular edema, right eye (E11.3311)</content>. Acuity 71 letters, from 64, after three injections; the retina clinic will now lengthen the interval. [S]<list><item>Continue retina-clinic treatment.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Hemoglobin A1c</td><td>Every three months when not at goal or after a change; every six months at goal</td><td>Completed today</td><td>7.6%, from 8.6%</td></tr><tr><td>Medication safety</td><td>Continuous glucose monitor review: time in range and time below range</td><td>Every visit</td><td>Completed today</td><td>Time in range 66%; time below 70 mg/dL 0.8%; none below 54 mg/dL</td></tr><tr><td>Medication safety</td><td>Hypoglycemia events, show-day plan, and glucagon</td><td>Every visit</td><td>Completed today</td><td>No level 2 or 3 lows; ate before every late show; glucagon unused</td></tr><tr><td>Medication safety</td><td>Empagliflozin safety: genital infection, volume, and sick-day rules</td><td>At the start and every visit</td><td>Completed today</td><td>No genital infection; no dizziness on stage</td></tr><tr><td>Laboratory</td><td>Creatinine, eGFR, and potassium</td><td>Within three months of starting an SGLT2 inhibitor, then every six to twelve months; potassium on SGLT2 inhibitor and rivaroxaban review</td><td>Completed today</td><td>Creatinine 0.96 mg/dL, eGFR 64, potassium 4.6, sodium 140 mmol/L</td></tr><tr><td>Laboratory</td><td>Urine albumin-creatinine ratio</td><td>Yearly</td><td>Up to date</td><td>18 mg/g at intake</td></tr><tr><td>Laboratory</td><td>Lipid panel</td><td>4 to 12 weeks after a statin or other lipid-lowering change, then yearly</td><td>Deferred</td><td>Due 4 to 12 weeks after atorvastatin was raised; drawn today at 13 weeks, one week late, because she was on tour. LDL 64 mg/dL, above goal; no harm from the one-week delay. Corrective action: lipid tests after any change are booked before she leaves on tour</td></tr><tr><td>Examination</td><td>Foot inspection, protective sensation, and pulses</td><td>Every visit with peripheral artery disease and foot deformity (IWGDF risk 2); podiatry every three to six months</td><td>Completed today</td><td>No ulcer; protective sensation intact; podiatry seen in June, next visit in September</td></tr><tr><td>Imaging</td><td>Ankle-brachial and toe-brachial indices</td><td>At diagnosis; repeat with arterial duplex six months after the consultation or with any change in symptoms</td><td>Up to date</td><td>Repeat with duplex at the six-month vascular review</td></tr><tr><td>Examination</td><td>Walking distance and claudication symptoms</td><td>Every visit</td><td>Completed today</td><td>About three blocks before calf pain, from one and a half</td></tr><tr><td>Self-management</td><td>Supervised exercise therapy</td><td>Three times a week for twelve weeks</td><td>Completed today</td><td>Ten of twelve weeks done; home plan followed on tour</td></tr><tr><td>Imaging</td><td>Retinal examination and visual acuity</td><td>With each retina-clinic treatment while macular edema is treated; at least yearly in both eyes</td><td>Completed today</td><td>Acuity 71 letters right and 81 left; three injections; retina clinic told about semaglutide</td></tr><tr><td>Examination</td><td>Blood pressure</td><td>Every visit</td><td>Completed today</td><td>122/68 mmHg</td></tr><tr><td>Examination</td><td>Weight and BMI</td><td>Every visit</td><td>Completed today</td><td>82.1 kg, down 1.9 kg</td></tr><tr><td>Medication safety</td><td>Bleeding on rivaroxaban and aspirin</td><td>At the start and every visit</td><td>Completed today</td><td>No bleeding</td></tr><tr><td>Medication safety</td><td>Semaglutide tolerance: nausea, appetite, and dose step</td><td>At the start and each dose step</td><td>Completed today</td><td>Starting today; nausea and dose steps explained</td></tr><tr><td>Self-management</td><td>Access and equity: tour-date scheduling, video visits, large print, drug costs</td><td>Every visit</td><td>Completed today</td><td>Semaglutide cost checked with her Part D plan; next visit set before the autumn tour</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>No glucose below 70 mg/dL on most days and no level 2 or 3 low (below 54 mg/dL or needing help) through six months. In progress; target 2026-10-26 [S]</item><item>A1c below 7.5% by six months. In progress; target 2026-10-26 [S]</item><item>LDL cholesterol below 55 mg/dL by six months. In progress; target 2026-10-26 [S]</item><item>Walk at least four blocks without stopping by six months. In progress; target 2026-10-26 [S]</item><item>No foot ulcer, and protective footwear on and off stage, through six months. In progress; target 2026-10-26 [S]</item></list><paragraph>Guideline basis: Standards of Care in Diabetes—2026 (2026); Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update) (2023); 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease (2024); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); CMID: Clinical Monitoring Intelligence Database, diabetes mellitus (type 2) and ischemic heart disease monographs (2026); Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial (2025)</paragraph><paragraph>Follow-up: Semaglutide dose step in four weeks, by video visit if she is touring. Podiatry in September. Review in eleven weeks with A1c, lipids, and kidney tests; zoster vaccine dose 1 at that visit. Next scheduled visit 2026-10-26: five-and-a-half-month review: A1c, lipids, walking distance, revascularization decision, foot and eye follow-up. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
